Kansas Hospitals Renew Pitch to Expand Medicaid Amid Mounting Losses
The problem in Kansas is the same as other states without Medicaid expansion: the ACA envisioned universal coverage, and funds to treat the uninsured are dwindling because it was expected that patients who are now in a "gap" would have insurance.
Clinton Seeks Cap on Drug Expenses, Would Let Medicare Negotiate
Hillary Clinton unveiled a plan in Iowa that features a $250 per month cap on drug costs for patients with chronic conditions. This comes 2 weeks after her chief rival for the Democratic nomination, US Senator Bernie Sanders of Vermont, introduced a bill aimed at reining in drug costs. In the summer, The American Journal of Managed Care said polling showed that rising drug costs were poised to become a major issue in the 2016 campaign.
For Now, PBMs Just Say No to High-Cost PCSK9 Inhibitors
When prices of the first 2 entrants of this new class of cholesterol-lowering drugs came in well above expectations, leading PBMs announced plans to limit who could gain access and sent a clear message to the drug makers: get ready to negotiate.
Empagliflozin Shown to Cut Mortality Risk in Long-Term CV Outcomes Trial
Presentation of results at the European Association for the Study of Diabetes follows the announcement of topline results in August. For years, researchers and pharmaceutical leaders alike wondered if a diabetes therapy would be shown to have a cardioprotective effect.
What "Behavioral Change" Looks Like From the Front Lines: Visiting Jefferson Hospital
Evidence-Based Diabetes Management gained exclusive access to the Comprehensive Weight Management Program for a view of what "behavioral change" really means for patients overcoming obesity and for the clinicians managing their care.
Cancer Drugs Driving 340B Growth Even More Than Understood, Report Finds
The report, commissioned by the Community Oncology Alliance, finds that Medicare Part B cancer drug spending rose 123% in 340B hospitals from 2010 to 2013, but only 31% in non-340B hospitals; it fell 5% in community practices in the same period.
Deciding Which Bipolar Patients Need Antidepressants Remains Challenging
The limited number of FDA approved medications indicated for bipolar depression makes treatment challenging, said Terence A. Ketter, MD. Several drugs that have been tested could not meet standards to receive an indication.
Telehealth Offers Effective Way to Treat Veterans for PTSD
Presenters who have implemented telehealth to treat PTSD through the VA in Charleston, South Carolina, say it will help address shortages of mental health providers and offer care that is just as good as in-person treatment.
Human Nature Limits Good Medication Adherence in Bipolar Patients, Jamison Says
Studies show medication adherence in bipolar disorder is only about 40% to 45%, but this dangerous, progressive disease has a high suicide rate. Adherence is complicated by the fact that patients may miss the mild "high" that many associate with periods of creativity, says Kay Redfield Jamison, PhD.